Daniel Yohannes

Title: The Innovative Contributions of Daniel Yohannes

Introduction

Daniel Yohannes is a notable inventor based in New London, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with various receptors in the brain. With a total of 5 patents to his name, his work has implications for the treatment of various neurological conditions.

Latest Patents

One of his latest patents involves heterocyclic compounds as ligands of the GABAA receptor. This invention discloses heterocyclic compounds that serve as highly selective agonists, antagonists, or inverse agonists for GABA brain receptors. These compounds may also act as prodrugs of agonists, antagonists, or inverse agonists for GABA brain receptors. Another significant patent pertains to muscarinic receptor agonists, which relates to a novel class of partial or full muscarinic receptor agonists. This invention includes intermediates for their preparation, as well as pharmaceutical compositions and methods of use for the treatment or prevention of diseases mediated by muscarinic receptor agonism.

Career Highlights

Throughout his career, Daniel Yohannes has worked with prominent companies in the pharmaceutical industry, including Neurogen Corporation and Pfizer. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Daniel has collaborated with notable colleagues such as George D. Maynard and Xiaojun Liu. These partnerships have further enhanced his innovative work and expanded the impact of his inventions.

Conclusion

Daniel Yohannes is a distinguished inventor whose work in the pharmaceutical field has led to significant advancements in the treatment of neurological conditions. His patents reflect a commitment to innovation and a deep understanding of receptor interactions.